EW News and Press, Edwards Lifesciences Corporation From 01/24/23

EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JANUARY 31, 2023 PR Newswire IRVINE, Calif. , Jan. 24, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW ) plans to announce its operating results for the quarter ended December 31, 2022 aft...

Summary The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. However, they offer varying financial profiles. To understand where opportunity may lie, I ranked the group according to various financial metrics. Read on to se...

Summary Edwards Lifesciences is a high quality business by any and all measures. Edwards has an excellent financial profile, a history of organic growth as opposed to growth via M&A, and a history of returning cash to shareholders via share repurchases. Now that the earnings mul...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...

EDWARDS LIFESCIENCES TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire IRVINE, Calif. , Jan. 5, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference...

Summary Fundsmith’s 13F portfolio value decreased from $23.45B to $21.07B this quarter. They added Otis Worldwide while decreasing Intuit and PayPal Holdings. The top three positions are Microsoft, Philip Morris International, and Estee Lauder, and they add up to ~23% of the ...

Summary Down 40%+ this year, EW is now trading at levels not seen in years. I believe the sell-off is unjust, and investors over the next few months will benefit immensely. This article will cover why past performance almost guarantees continued success. Introduction W...

Summary Wedgewood Partners' 13F portfolio value decreased from $579M to $532M this quarter. They decreased Taiwan Semi and Starbucks during the quarter. Their top five positions are at 36% of the overall portfolio. This article is part of a series that provides an ongoing ...

Edwards Lifesciences ( NYSE: EW ) has announced the planned retirement of chairman and CEO, Michael Mussallem. At the company's 2023 annual meeting on May 11, 2023, Mussallem will stand for election as non-executive chairman of Edwards' board. Bernard Zovighian, currently corp...

EDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE PR Newswire IRVINE, Calif. , Dec. 8, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its ...